查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1553476

临床试验管理服务市场规模、份额、趋势分析报告：按服务、适应症、按最终用途、按地区、细分市场预测，2024-2030 年

Clinical Trial Management Services Market Size, Share & Trends Analysis Report By Services (Regulatory submissions, Medical Writing), By Indication (Oncology, Diabetes), By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 145 Pages | 商品交期: 2-10个工作天内

价格

临床试验管理服务市场成长与趋势：

Grand View Research, Inc. 的最新报告显示，到 2030 年，全球临床试验管理服务市场规模预计将达到 538.5 亿美元。

预计2024年至2030年该市场将以8.25%的复合年增长率扩张。临床试验活动外包趋势的增加、先进治疗方法研发的活性化以及临床试验的全球化是推动市场成长的主要因素。

过去20年来，临床试验的数量显着增加。这背后是对疗效提高的新药不断增长的需求以及尖端医疗技术的传播。根据 Clinical Trials.gov 统计，截至 2022 年 4 月，今年的临床试验总数已超过 410,903 项，而 2020 年为 325,773 项。

临床监测、资料管理、现场监测和医学写作服务等临床试验管理服务具有成本效益且节省时间。它们还可以协调机构之间的临床资料并降低失败率。此外，云端处理、人工智慧（AI）、巨量资料处方、预测分析、医疗物联网和行动技术等数位技术的整合仍然是一项重大发展。这些技术在提高生产力和加快临床试验步伐方面显示出巨大潜力。

COVID-19大流行对市场产生了重大影响。 COVID-19 的疫情对市场产生了重大影响，为进行临床试验和限制现场监测访问的替代解决方案带来了意想不到的紧迫性。为了限制 COVID-19 的传播并同时保持临床研究的正常运转，研究人员转向了远端临床试验监测服务和平台。例如，根据 2020 年佛罗伦萨调查，超过 60% 的临床试验中心和临床试验申办者表示，他们对临床研究远端现场监测解决方案的接受度超过 50%。

临床试验管理服务市场报告亮点

  • 临床试验监测领域占市场主导地位，2023年收益占有率为27.64%。临床试验数量的增加和临床试验监测技术的进步是推动成长的主要因素。
  • 肿瘤学领域在2023年占据市场主导地位，收益占有率为37.05%，预计在预测期内将以8.45%的最快复合年增长率增长。
  • 医药细分市场占据主导地位，2023 年销售额份额为 38.96%。这很大程度得益于过去二十年不断增加的研发投入和新药的开发。
  • 北美临床试验管理服务市场在2023年以34.96%的最大收益占有率占据全球主导地位。对新治疗方法和药物的需求导致该全部区域临床试验的激增。
  • 预计亚太地区临床试验管理服务市场在预测期内将以最快的复合年增长率成长。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章临床试验管理服务市场的变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 配套市场前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 临床试验管理服务市场：分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19 影响分析

第四章 临床试验管理服务市场：按服务分类的估计和趋势分析

  • 细分仪表板
  • 全球临床试验管理服务市场，按服务分類的差异分析
  • 2018-2030年全球临床试验管理服务市场规模及趋势分析（按服务）
  • 临床试验监测
  • 监理意见书
  • 临床试验资料管理
  • 医学写作
  • 现场管理
  • 计划管理
  • 其他的

第五章 临床试验管理服务市场：按适应症估计与趋势分析

  • 细分仪表板
  • 全球临床试验管理服务市场，依适应症的变异分析
  • 2018-2030年全球临床试验管理服务市场规模与趋势分析（依适应症）
  • 自体免疫/发炎
  • 疼痛管理
  • 肿瘤学
  • 中枢神经系统症状
  • 糖尿病
  • 肥胖
  • 心血管
  • 其他的

第六章 临床试验管理服务市场：依最终用途分类的估计与趋势分析

  • 细分仪表板
  • 全球临床试验管理服务市场，依最终用途分類的变异分析
  • 2018-2030 年全球临床试验管理服务市场规模与趋势分析（依最终用途）
  • 药品
  • 生物製药
  • 医疗设备

第七章 临床试验管理服务市场：区域估计与趋势分析

  • 区域市场仪表板
  • 全球区域市场概述
  • 2018-2030年市场规模、预测趋势分析：
  • 北美洲
    • 2018 年至 2030 年市场估计与预测
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 2018 年至 2030 年市场估计与预测
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 2018 年至 2030 年市场估计与预测
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 2018 年至 2030 年市场估计与预测
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 2018 年至 2030 年市场估计与预测
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 市场参与企业分类
    • 市场领导者
    • 新兴玩家
  • 服务热力图分析（玩家间比较分析）
  • 公司简介
    • CTI Clinical Trial &Consulting
    • Charles River Laboratories
    • Medpace Holdings, Inc.
    • Wuxi Apptec
    • SGS Societe Generale de Surveillance SA
    • Laboratory Corporation of America Holdings
    • IQVIA, Inc.
    • Syneous Health
    • Atlantic Research Group
    • ICON Plc
Product Code: GVR-4-68039-993-8

Clinical Trial Management Services Market Growth & Trends:

The global clinical trial management services market size is anticipated to reach USD 53.85 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.25% from 2024 to 2030. The increasing trend of outsourcing clinical trial activities, the rise in research and development of advanced therapies, and the globalization of clinical trials are a few key factors driving the growth of the market.

The number of clinical trials has significantly increased in the past two decades. This is due to the rising need for novel pharmaceutical products with improved efficacy as well as the increasing penetration of cutting-edge medical technologies. According to Clinical trials.gov, the total number of clinical trials accounted for 325,773 in 2020, whereas, as of April 2022, the number of clinical trials this year totaled more than 410,903.

Clinical trial management services such as clinical monitoring, data management, site monitoring, and medical writing service are cost-effective and time-saving. These also harmonize clinical data across sites and failure rates. Furthermore, the integration of digital technologies, including cloud computing, Artificial Intelligence (AI), big data prescriptive, and predictive analytics, the Internet of Medical Things, and mobile technology remain major developments on the horizon. These technologies have shown great promise in improving productivity while accelerating the pace of clinical trials.

The COVID-19 pandemic significantly impacted the market. It created an unexpected urgency for alternative solutions to clinical trial execution, limiting on-site monitoring visits. It prompted researchers to use remote clinical trial monitoring services and platforms to reduce the spread of the COVID-19 infection as well as to simultaneously function in clinical research. For instance, according to the Florence survey in 2020, more than 60% of clinical study sites and clinical trial sponsors stated more than 50% acceptance of remote site monitoring solutions for clinical research.

Clinical Trial Management Services Market Report Highlights:

  • The clinical trial monitoring segment dominated the market with a revenue share of 27.64% in 2023. The rising number of clinical trials and technological advancements in trial monitoring are key factors driving the growth.
  • The oncology segment dominated the market with a revenue share of 37.05% in 2023 and is expected to grow at the fastest CAGR of 8.45% during the forecast period.
  • The pharmaceuticals segment dominated the market with a revenue share of 38.96% in 2023. This can be largely attributed to the rise in R&D investments and the development of new drugs over the past two decades.
  • North America clinical trial management services market dominated globally in 2023 with the largest revenue share of 34.96%. The demand for new therapies and drugs has led to a surge in clinical trials across the region.
  • Asia Pacific clinical trial management services market is expected to grow at the fastest CAGR over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Regional Scope
    • 1.1.2. Estimates and Forecast Timeline
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Purchased Database
    • 1.3.3. GVR's Internal Database
    • 1.3.4. Secondary Sources
    • 1.3.5. Primary Research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Validation
    • 1.5.1. Region Wise Market: Base Estimates
    • 1.5.2. Global Market: CAGR Calculation
  • 1.6. Model Details
    • 1.6.1. Commodity Flow Analysis (Model 1)
    • 1.6.2. Value-Chain-Based Sizing & Forecasting (Model 2)
    • 1.6.3. QFD Model Sizing & Forecasting (Model 3)
    • 1.6.4. Bottom-Up Approach (Model 4)
  • 1.7. List of Secondary Sources
  • 1.8. List of Abbreviations
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Clinical Trial Management Services Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing technological advancement in the clinical trial monitoring services
      • 3.2.1.2. Rise in R&D expenditure by pharmaceutical and biopharmaceutical companies
      • 3.2.1.3. Growth in the number of outsourced projects related to clinical trial management services
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost associated with clinical trial management services
      • 3.2.2.2. Stringent regulatory policies for clinical trial management services
  • 3.3. Clinical Trial Management Services Market: Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Clinical Trial Management Services Market: Services Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Clinical Trial Management Services Market, Services Movement Analysis
  • 4.3. Global Clinical Trial Management Services Market Size & Trend Analysis, by Services, 2018 to 2030 (USD Million)
  • 4.4. Clinical Trial Monitoring
    • 4.4.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 4.5. Regulatory Submissions
    • 4.5.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 4.6. Clinical Trial Data Management
    • 4.6.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 4.7. Medical Writing
    • 4.7.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 4.8. Site Management
    • 4.8.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 4.9. Project Management
    • 4.9.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 4.10. Others
    • 4.10.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)

Chapter 5. Clinical Trial Management Services Market: Indication Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Clinical Trial Management Services Market, Indication Movement Analysis
  • 5.3. Global Clinical Trial Management Services Market Size & Trend Analysis, by Indication, 2018 to 2030 (USD Million)
  • 5.4. Autoimmune/Inflammation
    • 5.4.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 5.5. Pain Management
    • 5.5.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 5.6. Oncology
    • 5.6.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 5.7. CNS Conditions
    • 5.7.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 5.8. Diabetes
    • 5.8.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 5.9. Obesity
    • 5.9.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 5.10. Cardiovascular
    • 5.10.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 5.11. Others
    • 5.11.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)

Chapter 6. Clinical Trial Management Services Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Clinical Trial Management Services Market, End Use Movement Analysis
  • 6.3. Global Clinical Trial Management Services Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Pharmaceuticals
    • 6.4.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 6.5. Biopharmaceuticals
    • 6.5.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 6.6. Medical Devices
    • 6.6.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)

Chapter 7. Clinical Trial Management Services Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Dashboard
  • 7.2. Global Regional Market Snapshot
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Scenario
      • 7.4.2.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Scenario
      • 7.4.3.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Scenario
      • 7.4.4.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Scenario
      • 7.5.2.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Scenario
      • 7.5.3.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Scenario
      • 7.5.4.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Scenario
      • 7.5.5.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Scenario
      • 7.5.6.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Scenario
      • 7.5.7.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competitive Scenario
      • 7.5.8.3. Regulatory Scenario
      • 7.5.8.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Competitive Scenario
      • 7.5.9.3. Regulatory Scenario
      • 7.5.9.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.6.2. China
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Scenario
      • 7.6.2.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.6.3. Japan
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Scenario
      • 7.6.3.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Scenario
      • 7.6.4.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Scenario
      • 7.6.5.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Scenario
      • 7.6.6.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competitive Scenario
      • 7.6.7.3. Regulatory Scenario
      • 7.6.7.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Scenario
      • 7.7.2.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Scenario
      • 7.7.3.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Scenario
      • 7.8.2.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Scenario
      • 7.8.3.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. Regulatory Scenario
      • 7.8.4.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Competitive Scenario
      • 7.8.5.3. Regulatory Scenario
      • 7.8.5.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
    • 8.1.1. Market Leaders
    • 8.1.2. Emerging Players
  • 8.2. Service Heat Map Analysis (a comparative analysis of the players together)
  • 8.3. Company Profiles
    • 8.3.1. CTI Clinical Trial & Consulting
      • 8.3.1.1. Company Overview
      • 8.3.1.2. Financial Performance
      • 8.3.1.3. Service Benchmarking
      • 8.3.1.4. Strategic Initiatives
    • 8.3.2. Charles River Laboratories
      • 8.3.2.1. Company Overview
      • 8.3.2.2. Financial Performance
      • 8.3.2.3. Service Benchmarking
      • 8.3.2.4. Strategic Initiatives
    • 8.3.3. Medpace Holdings, Inc.
      • 8.3.3.1. Company Overview
      • 8.3.3.2. Financial Performance
      • 8.3.3.3. Service Benchmarking
      • 8.3.3.4. Strategic Initiatives
    • 8.3.4. Wuxi Apptec
      • 8.3.4.1. Company Overview
      • 8.3.4.2. Financial Performance
      • 8.3.4.3. Service Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. SGS Societe Generale de Surveillance SA
      • 8.3.5.1. Company Overview
      • 8.3.5.2. Financial Performance
      • 8.3.5.3. Service Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. Laboratory Corporation of America Holdings
      • 8.3.6.1. Company Overview
      • 8.3.6.2. Financial Performance
      • 8.3.6.3. Service Benchmarking
      • 8.3.6.4. Strategic Initiatives
    • 8.3.7. IQVIA, Inc.
      • 8.3.7.1. Company Overview
      • 8.3.7.2. Financial Performance
      • 8.3.7.3. Service Benchmarking
      • 8.3.7.4. Strategic Initiatives
    • 8.3.8. Syneous Health
      • 8.3.8.1. Company Overview
      • 8.3.8.2. Financial Performance
      • 8.3.8.3. Service Benchmarking
      • 8.3.8.4. Strategic Initiatives
    • 8.3.9. Atlantic Research Group
      • 8.3.9.1. Company Overview
      • 8.3.9.2. Financial Performance
      • 8.3.9.3. Service Benchmarking
      • 8.3.9.4. Strategic Initiatives
    • 8.3.10. ICON Plc
      • 8.3.10.1. Company Overview
      • 8.3.10.2. Financial Performance
      • 8.3.10.3. Service Benchmarking
      • 8.3.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 4 Global Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 5 Global Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 6 Global Clinical Trial Management Services, by Region, 2018 - 2030 (USD Million)
  • Table 7 North America Clinical Trial Management Services, by Country, 2018 - 2030 (USD Million)
  • Table 8 North America Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 9 North America Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 10 North America Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 11 U.S. Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 12 U.S. Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 13 U.S. Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 14 Canada Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 15 Canada Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 16 Canada Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 17 Mexico Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 18 Mexico Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 19 Mexico Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 20 Europe Clinical Trial Management Services, by Country, 2018 - 2030 (USD Million)
  • Table 21 Europe Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 22 Europe Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 23 Europe Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 24 Germany Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 25 Germany Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 26 Germany Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 27 UK Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 28 UK Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 29 UK Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 30 France Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 31 France Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 32 France Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 33 Italy Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 34 Italy Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 35 Italy Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 36 Spain Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 37 Spain Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 38 Spain Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 39 Denmark Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 40 Denmark Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 41 Denmark Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 42 Sweden Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 43 Sweden Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 44 Sweden Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 45 Norway Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 46 Norway Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 47 Norway Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Clinical Trial Management Services, by Country, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 52 China Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 53 China Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 54 China Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 55 Japan Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 56 Japan Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 57 Japan Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 58 India Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 59 India Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 60 India Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 61 South Korea Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 62 South Korea Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 63 South Korea Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 64 Australia Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 65 Australia Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 66 Australia Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 67 Thailand Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 68 Thailand Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 69 Thailand Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 70 Latin America Clinical Trial Management Services, by Country, 2018 - 2030 (USD Million)
  • Table 71 Latin America Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 72 Latin America Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 73 Latin America Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 74 Brazil Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 75 Brazil Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 76 Brazil Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 77 Argentina Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 78 Argentina Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 79 Argentina Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Clinical Trial Management Services, by Country, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 84 South Africa Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 85 South Africa Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 86 South Africa Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 90 UAE Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 91 UAE Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 92 UAE Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 95 Kuwait Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Clinical Trial Management Services, Market Segmentation
  • Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 9 Porter's Five Forces Analysis
  • Fig. 10 PESTEL Analysis
  • Fig. 11 Regional Marketplace: Key Takeaways
  • Fig. 12 Global Clinical Trial Management Services, for Clinical Trial Monitoring, 2018 - 2030 (USD Million)
  • Fig. 13 Global Clinical Trial Management Services, for Regulatory Submissions, 2018 - 2030 (USD Million)
  • Fig. 14 Global Clinical Trial Management Services, for Clinical Trial Data Management, 2018 - 2030 (USD Million)
  • Fig. 15 Global Clinical Trial Management Services, for Medical Writing, 2018 - 2030 (USD Million)
  • Fig. 16 Global Clinical Trial Management Services, for Site Management, 2018 - 2030 (USD Million)
  • Fig. 17 Global Clinical Trial Management Services, for Project Management, 2018 - 2030 (USD Million)
  • Fig. 18 Global Clinical Trial Management Services, for Others, 2018 - 2030 (USD Million)
  • Fig. 19 Global Clinical Trial Management Services, for Autoimmune/Inflammation, 2018 - 2030 (USD Million)
  • Fig. 20 Global Clinical Trial Management Services, for Pain Management, 2018 - 2030 (USD Million)
  • Fig. 21 Global Clinical Trial Management Services, for Oncology, 2018 - 2030 (USD Million)
  • Fig. 22 Global Clinical Trial Management Services, for CNS Conditions, 2018 - 2030 (USD Million)
  • Fig. 23 Global Clinical Trial Management Services, for Diabetes, 2018 - 2030 (USD Million)
  • Fig. 24 Global Clinical Trial Management Services, for Obesity, 2018 - 2030 (USD Million)
  • Fig. 25 Global Clinical Trial Management Services, for Cardiovascular, 2018 - 2030 (USD Million)
  • Fig. 26 Global Clinical Trial Management Services, for Others, 2018 - 2030 (USD Million)
  • Fig. 27 Global Clinical Trial Management Services, for Pharmaceuticals, 2018 - 2030 (USD Million)
  • Fig. 28 Global Clinical Trial Management Services, for Biopharmaceuticals, 2018 - 2030 (USD Million)
  • Fig. 29 Global Clinical Trial Management Services, for Medical Devices, 2018 - 2030 (USD Million)
  • Fig. 30 Regional Outlook, 2023 & 2030
  • Fig. 31 North America Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 U.S. Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Canada Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Mexico Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Europe Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Germany Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 UK Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 France Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Italy Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Spain Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Denmark Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Sweden Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Norway Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Asia Pacific Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Japan Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 China Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 India Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Australia Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 South Korea Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Thailand Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Latin America Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Brazil Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Argentina Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Middle East and Africa Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 South Africa Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Saudi Arabia Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 UAE Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Kuwait Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)